Compounded Oral GLP-1 vs FDA-Approved: What's the Real Difference?
When you see oral semaglutide priced at $99/month from one provider and $149/month from another, the price difference reflects a fundamental distinction: compounded medications and FDA-approved medications are different products, made differently, tested differently, and regulated differently.
FDA-Approved Oral GLP-1s
FDA-approved medications (oral Wegovy, Foundayo) have undergone Phase 1, 2, and 3 clinical trials with thousands of participants. Their manufacturing processes are inspected by the FDA. Their absorption profiles, efficacy, and safety data are published in peer-reviewed journals. Their dosing is validated by measured blood levels in controlled studies.
When a provider prescribes FDA-approved oral Wegovy, you know exactly what you're getting: a tablet manufactured by Novo Nordisk in an FDA-inspected facility using SNAC absorption technology that has been clinically proven to deliver therapeutic semaglutide levels.
Compounded Oral GLP-1s
Compounded medications are prepared by licensed 503A compounding pharmacies based on individual prescriptions. They contain the same active ingredient (semaglutide) but are formulated differently — without SNAC technology — using the pharmacy's own delivery method (sublingual solution, dissolvable tablet, capsule, gummy).
Compounded medications are legal and have a legitimate place in healthcare. But they haven't undergone the same clinical trial process as FDA-approved drugs. The specific oral delivery formulations used by compounding pharmacies haven't been validated in large controlled studies for absorption, efficacy, or long-term safety.
Comparison at a Glance
| Factor | FDA-Approved | Compounded |
|---|---|---|
| Clinical trials | Phase 1-3, thousands of patients | None for the specific oral formulation |
| Manufacturing | FDA-inspected facilities | State-licensed 503A pharmacies |
| Absorption tech | SNAC (Wegovy) / small molecule (Foundayo) | Varies by pharmacy |
| Price range | $149–$399/mo | $99–$299/mo |
| Regulatory risk | None | FDA enforcement increasing |
Which Should You Choose?
If regulatory certainty, clinical validation, and proven absorption matter most to you, FDA-approved options are the clear choice. If price is the priority and you're comfortable with the trade-offs of a less-validated delivery method, compounded oral GLP-1s offer significant savings.
Many patients start with compounded options for affordability and switch to FDA-approved products as prices come down or as insurance coverage expands. Both pathways are legitimate — the key is understanding what you're getting.